SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-007127
Filing Date
2020-03-23
Accepted
2020-03-23 16:30:27
Documents
4
Period of Report
2020-03-18
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea119830-8k_artarathera.htm 8-K 23956
2 LETTER DATED MARCH 19, 2020 FROM ?ERNST AND YOUNG LLP TO THE SECURITIES AND EXCH ea119830ex16-1_artarathera.htm EX-16.1 3289
3 GRAPHIC logo.jpg GRAPHIC 14518
4 GRAPHIC logo2.jpg GRAPHIC 8080
  Complete submission text file 0001213900-20-007127.txt   59844
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
ArTara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 20735217
SIC: 2836 Biological Products, (No Diagnostic Substances)